Physician

Resty T Tibayan, MD

According to 2025 Medicare claims, Resty Tibayan, MD (NPI: 1508029208) practices hematology/oncology in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (NPI: 1598770471; TIN: 88-0350180) and primary practice location at 89052-9998.

Tibayan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 828 traditional Medicare patients, billed 237,963 HCPCS/CPT codes, and received $2,441,245 in Medicare payments. The top billing code was 82607 (Cyanocobalamin (vitamin b-12) level). Part D data shows 1,040 prescription claims across 223 beneficiaries totaling $2,142,231 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 37 claims. Open Payments data shows 156 records totaling $15,337. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $910,899 to $2,142,231. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $18,742 to $67,578.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	506	209,248	$2,023,984
2016	520	203,015	$2,345,744
2017	489	284,596	$2,414,059
2018	568	107,495	$639,732
2019	769	187,614	$1,947,752
2020	769	215,906	$2,152,930
2021	754	200,880	$1,920,711
2022	734	178,910	$2,171,518
2023	796	226,204	$2,185,181
2024	828	237,963	$2,441,245

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	182	1,733	$910,899
2016	164	1,495	$1,300,791
2017	176	1,447	$1,640,542
2018	287	857	$670,102
2019	248	1,115	$751,528
2020	244	1,262	$1,617,331
2021	227	1,178	$1,709,246
2022	241	1,390	$1,987,656
2023	230	1,080	$1,486,341
2024	223	1,040	$2,142,231

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	30	243	$42,590
2016	29	91	$26,820
2017	36	191	$36,339
2018	N/R	16	$301
2019	N/R	12	$1,246
2020	N/R	48	$3,628
2021	23	112	$8,683
2022	N/R	74	$3,045
2023	N/R	37	$17,916
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82607	Cyanocobalamin (vitamin b-12) level	417	631	$15
82746	Folic acid level, serum	418	691	$14
80053	Blood test, comprehensive group of blood chemicals	581	1,347	$10
36415	Insertion of needle into vein for collection of blood sample	603	1,517	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	613	1,659	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	18	504	$333,468
Xtandi	Enzalutamide	23	690	$329,504
Imbruvica	Ibrutinib	13	364	$213,656
Ibrance	Palbociclib	11	308	$176,694
Doptelet	Avatrombopag Maleate	11	330	$138,544

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	144	$3,280	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	12	$12,057	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Resty T. Tibayan, MD?

Tedicare shows public-source Medicare data for Resty T. Tibayan, MD (NPI 1508029208), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Resty T. Tibayan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Resty T. Tibayan, MD?

Resty T. Tibayan, MD is linked to ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (billing NPI 1598770471) in the available physician profile data.

Does Resty T. Tibayan, MD have Open Payments data?

Resty T. Tibayan, MD has 156 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.